We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure

By HospiMedica International staff writers
Posted on 04 Aug 2022
Print article
Image: The global capsule endoscopy system market is growing at a rapid pace (Photo courtesy of Pexels)
Image: The global capsule endoscopy system market is growing at a rapid pace (Photo courtesy of Pexels)

Capsule endoscopy is generally a non-invasive technique that enables complete examination of the gastrointestinal tract with the use of the disposable and wireless device known as the video capsule. The device is equipped with a light source, transmitter, battery, and camera. The video capsule captures the images in the small intestine, stomach, and esophagus that are further used to diagnose gastrointestinal diseases. The global capsule endoscopy system market is expanding at a rapid pace due to the rising demand for the procedure using minimally invasive diagnostic techniques, increase in the introduction of technologically advanced capsules, growth in the geriatric population, and rising prevalence of cancer around the world.

These are the latest findings of TMR Research (San Francisco, CA, USA), a provider of market research and consulting services.

Capsule endoscopy systems generally include software, sensor, data recorder, and work station, which are used in order to integrate them with wireless capsules. Further, a data recorder is a device that is worn around a patient’s waist in order to transmit the data through sensors that are captured by a video capsule. The data recorder can locate the movement and position of the capsule that is the inside stomach. Going forward, technologically advanced and innovative products are likely to gain commercialization due to growing R&D activities for product development. This is expected to provide further growth impetus to the global capsule endoscopy system market in the near future. However, the risks of capsule retention, limited reimbursement, and high endoscopy treatment costs are expected to limit market growth.

Geographically, Europe, LAMEA, Asia Pacific, and North America are the world’s most lucrative markets for capsule endoscopy systems. North America is expected to dominate the global capsule endoscopy system market due to the growing preference for minimally invasive screening procedures, increasing number of technologically advanced systems and products, and improvement in healthcare infrastructure in the region.

Related Links:
TMR Research 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Pediatric Cast Saw
CSP-201 Quietcast
New
Critical Care Cart
Avalo

Print article

Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more